Visx's Laser System gains supplemental PMA
This article was originally published in Clinica
Executive Summary
The STAR S4 IR, an excimer laser system developed by Visx, has gained a supplemental PMA, allowing it to be used in the US to treat myopia - shortsightedness - by removing tissue from the centre of the cornea to flatten it. It can also treat astigmatism by flattening the central cornea by different amounts and at different orientations to correct for uneven focus. It is approved to treat patients over 40 years of age with myopic astigmatism, and minimum pre-operative myopia in their non-dominant eye at least as great as their targeted eye.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.